Flux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs

PLoS Computational Biology

Volumn 1, Issue 5, 2005, Pages 0349-0358

  Raman, Karthik ^a   Rajagopalan, Preeths ^a   Chandra, Nagasimia ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; HYDRAZINE; METABOLISM; TUBES (COMPONENTS);

ANTI TUBERCULARS; BALANCE ANALYSIS; BIOCHEMICAL STUDIES; COMPREHENSIVE MODELING; DRUG DESIGN; DRUG TARGETS; FLUX BALANCE ANALYSIS; GENETIC STUDIES; MICROBIA; MYCOLIC ACIDS;

PROTEINS;

EID: 33847654799     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0010046.eor     Document Type: Article

References (59)

1. Smith I (2003) Mycobacterium tuberculosis: Pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16: 463-496.
2. Barry CE III, Lee RE, Mdluli K, Simpson AE, Schroeder BG, et al. (1998) Mycolic acids: Structure, biosynthesis and physiological functions. Prog Lipid Res 37: 143-179.
3. Dubnau E, Chan J, Raynaud C, Mohan V, Lane elle M, et al. (2000) Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36: 630-637.
4. Glickman M, Cox J, Jacobs W (2000) A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 5: 717-727.
5. Crick DC, Mahapatra S, Brennan PJ (2001) Biosynthesis of the arabinogalactanpeptidoglycan complex of Mycobacterium tuberculosis. Glycobiology 11: 107R-118R.
6. Takayama K, Wang C, Besra GS (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18: 81-101.
7. Draper P, Daffe M (2005) The cell envelope of Mycobacterium tuberculosis with special reference to the capsule and outer permeability barrier. In: Cole ST, editor. Tuberculosis and the tubercle bacillus. Washington, D.C.: American Society of Microbiology Press. pp. 261-273
8. Pasqualoto KFM, Ferreira EI, Santos-Filho OA, Hopfinger AJ (2004) Rational design of new antituberculosis agents: Receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives. J Med Chem 47: 3755-3764.
9. Lei B, Wei C, Tu S (2000) Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inhA inhibitor. J Biol Chem 275: 2520-2526.
10. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um K, et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
11. Ma H, Zeng AP (2003) Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms. Bioinformatics 19: 270-277.
12. Bonarius HPJ, Schmid G, Tramper J (1997) Flux analysis of underdetermined metabolic networks: The quest for the missing constraints. Trends Biotech 15: 308-314.
13. Schuster S, Dandekar T, Fell DA (1999) Detection of elementary flux modes in biochemical networks: A promising tool for pathway analysis and metabolic engineering. Trends Biotech 17: 53-60.
14. Voit EO (2000) Computational analysis of biochemical systems: A practical guide for biochemists and molecular biologists. Cambridge: Cambridge University Press. 531 p.
15. Stelling J, Klamt S, Bettenbrock K, Schuster S, Gilles ED (2002) Metabolic network structure determines key aspects of functionality and regulation. Nature 420: 190-193.
16. Cornish-Bowden A, Hofmeyr JHS (2002) The role of stoichiometric analysis in studies of metabolism: An example. J Theor Biol 216: 179-191.
17. Price ND, Papin JA, Schilling CH, Palsson BO (2003) Genome-scale microbial in silico models: The constraints-based approach. Trends Biotech 21: 162-169.
18. Segre D, Zucker J, Katz J, Lin X, D'haeseleer P, et al. (2003) From annotated genomes to metabolic flux models and kinetic parameter fitting. OMICS 7: 301-316.
19. Edwards JS, Palsson BO (1999) Systems properties of the Haemophilus influenzae Rd metabolic genotype. J Biol Chem 274: 17410-17416.
20. Forster J, Famili I, Fu P, Palsson BO, Nielsen J (2003) Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res 13: 244-253.
21. Edwards JS, Palsson BO (2000) The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities. Proc Natl Acad Sci U S A 97: 5528-5533.
22. Becker SA, Palsson BO (2005) Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: An initial draft to the two-dimensional annotation. BMC Microbiology 5: 8.
23. Schweizer E, Hofmann J (2004) Microbial type I fatty acid synthases (FAS): Major players in a network of cellular FAS systems. Microbiol Mol Biol Rev 68: 501-517.
24. Kikuchi S, Rainwater DL, Kolattukudy P (1992) Purification and characterization of an unusually large fatty acid synthase from Mycobacterium tuberculosis var. bovis BCG. Arch Biochem and Biophys 295: 318-326.
25. Choi KH, Kremer L, Besra GS, Rock CO (2000) Identification and substrate specificity of b-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J Biol Chem 275: 28201-28207.
26. Scarsdale JN, Kazanina G, He X, Reynolds KA, Wright HT (2001) Crystal structure of the Mycobacterium tuberculosis b-ketoacyl-acyl carrier protein synthase III. J Biol Chem 276: 20516-20522.
27. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
28. Kremer L, Dover L, Carre re S, Nampoothiri K, Lesjean S, et al. (2002) Mycolic acid biosynthesis and enzymic characterization of the betaketoacylACP synthase A-condensing enzyme from Mycobacterium tuberculosis. Biochem J 364: 423-430.
29. Marrakchi H, Ducasse S, Labesse G, Montrozier H, Margeat E, et al. (2002) MabA (FabG1), a Mycobacterium tuberculosis protein involved in the longchain fatty acid elongation system FAS-II. Microbiology 148: 951-960.
30. Quemard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, et al. (1995) Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34: 8235-8241.
31. Schaeffer ML, Agnihotri G, Volker C, Kallender H, Brennan PJ, et al. (2001) Purification and biochemical characterization of the Mycobacterium tuberculosis b-ketoacyl-acyl carrier protein synthases KasA and KasB. J Biol Chem 276: 47029-47037.
32. Phetsuksiri B, Jackson M, Scherman H, McNeil M, Besra GS, et al. (2003) Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis. J Biol Chem 278: 53123-53130.
33. Glickman M, Cahill S, Jacobs W (2001) The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J Biol Chem 276: 2228-2233.
34. Dinadayala P, Laval F, Raynaud C, Lemassu A, Laneelle M, et al. (2003) Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. J Biol Chem 278: 7310-7319.
35. George K, Yuan Y, Sherman D, Barry C (1995) The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2. J Biol Chem 270: 27292-27298.
36. Glickman MS (2003) The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the a-mycolic acid. J Biol Chem 278: 7844-7849.
37. Yuan Y, Barry CE III (1996) A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 93: 12828-12833.
38. Yuan Y, Lee R, Besra G, Belisle J, Barry C (1995) Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 92: 6630-6634.
39. Yuan Y, Crane D, Musser J, Sreevatsan S, Barry C (1997) MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis. J Biol Chem 272: 10041-10049.
40. Portevin D, de Sousa-D'Auria C, Montrozier H, Houssin C, Stella A, et al. (2005) The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth. J Biol Chem 280: 8862-8874.
41. Watanabe M, Aoyagi Y, Ridell M, Minnikin D (2001) Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147: 1825-1837.
42. Takayama K, Wang L, David HL (1972) Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2: 29-35.
43. Vilche ze C, Morbidoni HR, Weisbrod TR, Iwamoto H, Kuo M, et al. (2000) Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 182: 4059-4067.
44. Yuan Y, Zhu Y, Crane DD, Barry CE III (1998) The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol 29: 1449-1458.
45. Watanabe M, Aoyagi Y, Mitome H, Fujita T, Naoki H, et al. (2002) Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. Microbiology 148: 1881-1902.
46. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48: 77-84.
47. Segre D, Vitkup D, Church GM (2002) Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci U S A 99: 15112-15117.
48. Monahan IM, Betts J, Banerjee DK, Butcher PD (2001) Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiology 147: 459-471.
49. Mdluli K, Slayden RA, Zhu Y, Ramaswamy S, Pan X, et al. (1998) Inhibition of a Mycobacterium tuberculosis b-ketoacyl ACP synthase by isoniazid. Science 280: 1607-1610.
50. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2003) The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-D280.
51. Karp PD, Paley S, Romero P (2002) The pathway tools software. Bioinformatics 18: S1-S8.
52. Hucka M, Finney A, Bornstein B, Keating S, Shapiro B, et al. (2004) Evolving a lingua franca and associated software infrastructure for computational systems biology: The Systems Biology Markup Language (SBML) project. Syst Biol 1: 41-53.
53. Edwards JS, Covert M, Palsson BO (2002) Metabolic modelling of microbes: The flux-balance approach. Environ Microbiol 4: 133-133.
54. Kauffman KJ, Prakash P, Edwards JS (2003) Advances in flux balance analysis. Curr Opin Biotech 14: 491-496.
55. Alvarez-Vasquez F, Sims K, Cowart L, Okamoto Y, Voit E, et al. (2005) Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature 433: 425-430.
56. Edwards JS, Ibarra RU, Palsson BO (2001) In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol 19: 125-130.
57. Altschul SF, Madden TL, Scha ffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
58. Kremer L, Nampoothiri KM, Lesjean S, Dover LG, Grahami S, et al. (2001) Biochemical characterization of acyl carrier protein (AcpM) and malonylCoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem 276: 27967-27974.
59. Portevin D, De Sousa-D'Auria C, Houssin C, Grimaldi C, Chami M, et al. (2004) A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci U S A 101: 314-319.